One of the world’s largest Clinical Trial Organizations, PRA is transforming clinical trials through our people, innovation and operational transparency. Our 10,000+ employees operate in more than 80 countries, delivering a broad spectrum of full-service and Strategic/Embedded clinical trial solutions that meet the demands of a diverse marketplace.

Over the last 30+ years, PRA has established a reputation for specialized expertise and success in a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. Clients also benefit from our strategic investment in key therapeutic programs and research areas, including neurology/psychiatry, oncology/hematology, infectious diseases, biosimilar products, cardio-metabolic diseases and rare diseases.